Lundbeck sales beat expectations on virus-stockpiling
Share:
COPENHAGEN (Reuters) - Danish drugmaker Lundbeck beat first-quarter sales expectations on Tuesday and stuck to its annual forecast, helped by strong sales of drugs as patients requested longer prescriptions and stockpiled drugs due to the coronavirus pandemic."Demand has been strong, but we also recognize that we have benefited from patients gaining longer refill prescriptions as well as some stocking of products in many countries in response to the COVID-19 pandemic," Chief Executive Deborah..